Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;18(7):607-611.
doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.

Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia

Affiliations

Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia

Jessica Cusato et al. Pharmacogenomics. 2017 May.

Abstract

Aim: Mixed cryoglobulinemia (MC) is an extra hepatic hepatitis C virus related problem and different studies suggested genetics' role in predicting this complication. We evaluated the influence of SNPs in IL-28B, SLC29A1, SLC28A2, NT5C2, HNF4 and ABCB1 genes in MC prediction.

Patients & methods: SNPs were evaluated through real-time PCR.

Results: ABCB1 (gene encoding P-glycoprotein) 3435C>T SNP was associated with MC presence (p = 0.034): related to T allele carriers (CC vs CT/TT), we reached a p-value of 0.013. In the logistic regression analysis baseline viral load >600.000 IU/ml (p < 001), IL28B rs8099917/rs12979860 TT/CC (p < 0.001), NT5 (gene encoding for 5' nucleotidase) 153 TC (p = 0.012) and ABCB1 3435 CT/TT (p = 0.034) genotypes predicted MC presence.

Conclusion: These data could help clinicians to identify patients with higher probability to show MC extra hepatic complication.

Keywords: ABCB1; HCV; HCV extra hepatic manifestation; NT5; SNPs; cryoglobulin; pegylated interferon/ribavirin; pharmacogenetics.

PubMed Disclaimer